- Clinical Trials
- September 2021
- 213 Pages
Global
From €2289EUR$2,500USD£1,945GBP
Tachyarrhythmias drugs are a class of cardiovascular drugs used to treat abnormal heart rhythms, known as tachyarrhythmias. These drugs are used to restore the heart's normal rhythm and prevent further episodes of tachyarrhythmias. Commonly used tachyarrhythmias drugs include beta-blockers, calcium channel blockers, and antiarrhythmic agents. Beta-blockers are used to reduce the heart rate and reduce the risk of further episodes of tachyarrhythmias. Calcium channel blockers are used to reduce the force of contraction of the heart muscle and reduce the risk of further episodes of tachyarrhythmias. Antiarrhythmic agents are used to restore the heart's normal rhythm and prevent further episodes of tachyarrhythmias.
The tachyarrhythmias drug market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Pfizer, Merck, Novartis, Sanofi, and GlaxoSmithKline. Other companies in the market include AstraZeneca, Bristol-Myers Squibb, Boehringer Ingelheim, and Daiichi Sankyo. Show Less Read more